Medicines360 Proudly Supports the Expanding Access to Affordable Prescription Drugs and Medical Devices Act
This week, Senator Jacky Rosen introduced a bill that would make it easier for nonprofit pharmaceutical organizations in the United States to achieve their potential. The bill is called the Expanding Access to Affordable Prescription Drugs and Medical Devices Act. Medicines360 proudly supports this legislation. Sometimes, traditional pharmaceutical models fail to bring necessary drugs to […]
National Women’s Health Week
Medicines360 joins individuals and communities across the country in celebration of National Women’s Health Week, the annual weeklong observance led by the U.S. Department of Health and Human Services’ Office on Women’s Health (OWH). This year’s observance, perhaps more so than any in recent history, offers the nation a timely opportunity to center women and […]
Reflecting on Our Impact and Looking to the Future
After an amazing five years of working with some of the most passionate leaders in women’s health, I have ended my time as Medicines360 CEO to embark on a new venture. As I look back on the past five years, I’m incredibility proud of the impact we’ve made at Medicines360 for women. Not a day […]
Healthcare Policies Must Work for Women, Not Against Them
Challenges to accessing healthcare are not new for women; however, in the past year, several new roadblocks have hindered women’s access. These roadblocks span the gamut from the COVID-19 pandemic to policy changes that have impacted the fabric of women’s healthcare access. Also looming are significant changes to federal and state policies that threaten to […]
Expanding Contraceptive Options Through an Institutional Patient Assistance Program
“The program has absolutely made a difference for our clinic and patients. Patients wanted long-term contraception and were surprised that there was an option available to them free of charge.” – Michelle Hubbard, Dream Centers Women’s Clinic Without insurance coverage, the cost of birth control can be unaffordable. At Medicines360, our mission is to remove […]
Statement on Reproductive Justice
Medicines360 recognizes the importance of reproductive justice. We are aligned with the framework defined by SisterSong Women of Color Reproductive Justice Collective as “the human right to maintainpersonal bodily autonomy, have children, not have children, and parent the children we have in safe and sustainable communities.” The National Women’s Health Network (NWHN) and SisterSong issued […]
Statement on SCOTUS Ruling
On July 8, the Supreme Court of the United States (SCOTUS) ruled to uphold the Trump Administration’s regulations allowing employers and insurers to decline providing contraception coverage because of religious or moral objections. Implementation of these rules will immediately and significantly decrease contraceptive access for 70,500 to 126,400 women. When the rules were implemented in […]
Does a Low Cost for Clinics Mean More Underinsured Patients Are Able to Choose a Hormonal IUD? One Study in Utah Sought to Find Out
At the beginning of this year, an estimated 7.7 million women of reproductive age (15-44) in the United States were uninsured, with 2 million of these women living below the federal poverty level. As the ongoing novel coronavirus pandemic has led to historic numbers of unemployment claims, it is estimated that millions more have lost […]
Accessing Birth Control and Reproductive Health Services Amid COVID-19
Now more than ever, it is critical women have all the information and resources at their disposal to make informed decisions about their health. As the world grapples with the COVID-19 pandemic, women are facing more barriers than ever when it comes to accessing the birth control and reproductive health services they need. The healthcare […]
How America’s Nonprofit Pharma Industry Can Increase Access to Affordable Drugs
Access to affordable healthcare remains one of the largest issues in the United States. As we enter a new decade, we have the opportunity to create lasting change in drug pricing. Today, we join leaders across the nonprofit pharmaceutical industry to underscore the serious challenges facing Americans in accessing affordable drugs. Together, we hope to […]
